Not surprisingly, therefore, oncogenes and tumour-suppressor genes, such as P53, as well as the underlying genetic aberrations in pancreatic cancer have been the subject of intense research (Schleger et al, 2000). Here, TP53 is linked to pancreatic neoplasm.